OnCoCross Co Ltd (382150)

Currency in KRW
3,710
+300(+8.80%)
Closed·
Advertisement
382150 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3,3103,710
52 wk Range
3,30514,490
Key Statistics
Bid/Ask
3,700.00 / 3,710.00
Prev. Close
3,410
Open
3,310
Day's Range
3,310-3,710
52 wk Range
3,305-14,490
Volume
29.86K
Average Volume (3m)
308.19K
1-Year Change
-64.6667%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
382150 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
14/05/2026
EPS / Forecast
-216.84 / --
Revenue / Forecast
167.27M / --
EPS Revisions
Last 90 days

Compare 382150 to Peers and Sector

Metrics to compare
382150
Peers
Sector
Relationship
P/E Ratio
−4.5x−9.1x−0.4x
PEG Ratio
0.31−0.190.00
Price/Book
3.6x2.0x2.6x
Price / LTM Sales
87.5x7.6x3.0x
Upside (Analyst Target)
-−6.0%51.9%
Fair Value Upside
Unlock20.5%9.1%Unlock

Oncocross Co., Ltd. develops drugs for the treatment of cancers, rare diseases, and intractable diseases in South Korea. Its products pipeline includes OC101 for liver cirrhosis; OC101+OC111 for non-alcoholic steatohepatitis; OC201+OC202e for Inhibition of cancer metastasis; OC211, a Pan-KRAS Inhibitor; OC221, an immuno-oncology combination; OC514 to treat amyotrophic lateral sclerosis and Duchenne muscular dystrophy; and OC701 to treat atopic dermatitis. The company is also developing OJP3101 for metabolic disease; OJP3101 for Cardiovascular Disease; ODP9401 for metabolic disease; and ODP2201, ODP2301, and ODP2401 to treat oncology-related diseases. It has a collaboration agreement with various pharmaceutical companies, research institutes, and bio-techs. The company was founded in 2015 and is based in Seoul, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
5.39M44.21%18.87B
Public Companies & Retail Investors
6.80M55.79%23.81B
Total
12.2M100.00%42.69B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
InterVest8.10%988,1433,458,501
InterVest Deeptech Investment Fund4.58%558,6711,955,349

FAQ

What Is the OnCoCross (KOSDAQ: 382150) Share Price Today?

The OnCoCross stock price today is 3,710 KRW.

What Stock Exchange Does OnCoCross (382150) Trade On?

OnCoCross is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for OnCoCross?

The stock symbol (also called a 'ticker') for OnCoCross is "382150."

What Is the Current OnCoCross Market Capitalisation?

As of today, OnCoCross (KOSDAQ: 382150) market cap is 41.59B KRW.

What Is OnCoCross's (382150) Earnings Per Share (TTM)?

The OnCoCross EPS is currently -774 (Trailing Twelve Months).

Is 382150 a Buy or Sell From a Technical Analyst Perspective?

Based on today's OnCoCross moving averages and other technical indicators, the daily buy/sell signal for 382150 stock is Strong Sell.

How Many Times Has OnCoCross Stock Split?

OnCoCross has split 0 times. (See the 382150 stock split history page for full effective split date and price information.)

What is the current trading status of OnCoCross (KOSDAQ: 382150)?

As of 10/07/2026, OnCoCross (382150) is trading at a share price of 3,710 KRW, with a previous close of 3,410 KRW. The stock has fluctuated within a day range of 3,310 KRW to 3,710 KRW, while its 52-week range spans from 3,305 KRW to 14,490 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.